Press releases
- Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
- Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.
- Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
- Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
Key statistics
On Tuesday, Accelerate Diagnostics Inc (AXDX:MEX) closed at 15.60, 4.00% above its 52-week low of 15.00, set on Apr 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 15.60 |
Average volume | -- |
---|---|
Shares outstanding | 22.05m |
Free float | 13.62m |
P/E (TTM) | -- |
Market cap | 19.45m USD |
EPS (TTM) | -4.54 USD |
Data delayed at least 20 minutes, as of Apr 23 2024 12:30 BST.
More ▼